Clinical course after surgical treatment of active isolated native mitral valve endocarditis

M Wilbring1, K Alexiou, M Tuan Nguyen

  • 1Department of Cardiac Surgery, University Heart Center, Dresden, Germany - manuel.wilbring@gmail.com.

Abstract

Insights

Isolated mitral valve endocarditis (MVE) patients often face surgical delays and present with severe sepsis. Cardiac surgery offers good results, but long-term survival depends on managing extracardiac conditions.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Cardiac Surgery

Background:

  • Isolated mitral valve endocarditis (MVE) is a distinct subgroup of native infective valve endocarditis (NVE).
  • Characterizing MVE and analyzing surgical outcomes is crucial for improving patient management.

Purpose of the Study:

  • To characterize isolated mitral valve endocarditis (MVE).
  • To analyze the clinical course and outcomes of patients with MVE undergoing cardiac surgery.

Main Methods:

  • Retrospective analysis of 474 patients with NVE from 1997-2011.
  • Identified 89 patients (18.8%) with MVE, analyzing demographics, comorbidities, surgical procedures, and outcomes.
  • Follow-up data comprised 267 patient-years.

Main Results:

  • A significant delay (4.7±1.2 weeks) between symptom onset and surgery was observed, with many patients critically ill.
  • MVE patients had higher rates of stroke, atrial fibrillation, CAD, and COPD; Staphylococcus aureus was the predominant pathogen.
  • Early mortality (6.7%) was linked to sepsis; prolonged ICU stay and ventilation increased in-hospital death risk. Five-year survival was 59.6%, impacted by extracardiac comorbidities.

Conclusions:

  • Isolated MVE presents unique challenges including delayed diagnosis, specific microbiological profiles, and increased stroke prevalence.
  • Cardiac surgery for MVE can achieve favorable clinical results.
  • Mid-term survival is significantly influenced by the presence of extracardiac comorbidities.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
390
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
539
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
894
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
691
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
565
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
953